// App-Quantinova.ai

: Impact of once-daily single inhaler triple therapy on healthcare resource utilization and associated costs in COPD patients in Spain

Researchers

Presenter

  • Laura Atienza

Principal Investigators

  • Nicole Benjamin

  • Melanie Schroeder

  • Laura Amanda Vallejo-Aparicio

  • Chandroday Biswas

  • Dhvani Shah

  • Afisi S. Ismaila

Medical Centers

  • GSK, Madrid, Spain

  • Evidera, Seattle, United States of America

  • GSK, Brentford, United Kingdom

  • ICON, Bengaluru, India

  • IQVIA, New York, United States of america

  • GlaxoSmithKline plc, Collegeville, United States of America

Locations

  • Spain

  • United States

  • United Kingdom

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT02345161

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved